Potent and Specific Antitumor Efficacy of CMC-544, a CD22-Targeted Immunoconjugate of Calicheamicin, against Systemically Disseminated B-Cell Lymphoma
暂无分享,去创建一个
N. Damle | E. Boghaert | J. Dijoseph | Maureen M. Dougher | A. Kunz | P. Hamann | M. Dougher | M. Goad | P. R. Hamann